Table 1.
The relationship between s-eotaxin-1 levels and pathologic variables in gastric cancer patients.
| Variables | n | S-eotaxin, pg/mL median (interquartile range) | P |
|---|---|---|---|
| Age, y | |||
| <50 | 9 | 81.2 (±13.70) | 0.681 |
| 50–60 | 12 | 76.8 (±19.56) | |
| >60 | 39 | 72.2 (±16.20) | |
| Sex | |||
| Male | 40 | 76.08 (±16.74) | 0.845 |
| Female | 20 | 71.38 (±16.44) | |
| Tumor localization | |||
| Cardia/Fundus | 25 | 74.35 (±15.00) | 0.354 |
| Corpus | 7 | 79.49 (±18.54) | |
| Antrum | 28 | 73.41 (±17.95) | |
| Differentiation | |||
| Well | 9 | 72.08 (±18.53) | 0.299 |
| Moderate | 12 | 80.26 (±11.62) | |
| Poor | 33 | 73.65 (±18.35) | |
| Undifferentiated | 6 | 71.38 (±12.86) | |
| Tumor size | |||
| ≤4 cm | 15 | 78.25 (±14.83) | 0.271 |
| 4 cm< | 39 | 74.00 (±17.64) | |
| Lymph node metastases (N) | |||
| 0 | 9 | 75.82 (±19.19) | 0.823 |
| I | 8 | 80.15 (±14.26) | |
| II | 17 | 74.09 (±14.51) | |
| IIIA | 11 | 70.51 (±20.02) | |
| IIIB | 11 | 75.59 (±19.03) | |
| Positive lymph node ratio (%) | |||
| 0 | 9 | 75.82 (±19.19) | 0.547 |
| 1–9 | 10 | 80.30 (±13.78) | |
| 10–25 | 12 | 69.67 (±11.74) | |
| 26< | 25 | 74.75 (±19.39) | |
| TNM Stage | |||
| I/II (early gastric cancer) | 17 | 78.29 (±15.47) | 0.427 |
| III/IV (late gastric cancer) | 43 | 73.02 (±17.04) | |
| Perineural invasion | |||
| Positive | 46 | 74.40 (±16.67) | 0.831 |
| Negative | 9 | 74.12 (±18.14) | |
| Vascular invasion | |||
| Positive | 46 | 74.77 (±16.76) | 0.898 |
| Negative | 9 | 72.23 (±17.45) |